Cargando…
Peroxisome Proliferator-Activated Receptor Alpha Mediates the Beneficial Effects of Atorvastatin in Experimental Colitis
The current therapeutic options for Inflammatory Bowel Diseases (IBD) are limited. Even using common anti-inflammatory, immunosuppressive or biological therapies, many patients become unresponsive to the treatments, immunosuppressed or unable to restrain secondary infections. Statins are cholesterol...
Autores principales: | Basso, Paulo José, Sales-Campos, Helioswilton, Nardini, Viviani, Duarte-Silva, Murillo, Alves, Vanessa Beatriz Freitas, Bonfá, Giuliano, Rodrigues, Cassiano Costa, Ghirotto, Bruno, Chica, Javier Emílio Lazo, Nomizo, Auro, Cardoso, Cristina Ribeiro de Barros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382038/ https://www.ncbi.nlm.nih.gov/pubmed/34434187 http://dx.doi.org/10.3389/fimmu.2021.618365 |
Ejemplares similares
-
Adrenal-Derived Hormones Differentially Modulate Intestinal Immunity in Experimental Colitis
por: de Souza, Patrícia Reis, et al.
Publicado: (2016) -
Association among genetic predisposition, gut microbiota, and host immune
response in the etiopathogenesis of inflammatory bowel disease
por: Basso, P.J., et al.
Publicado: (2014) -
Classical and recent advances in the treatment of inflammatory bowel
diseases
por: Sales-Campos, H., et al.
Publicado: (2014) -
Morinda citrifolia (Noni) Fruit Juice Reduces Inflammatory Cytokines Expression and Contributes to the Maintenance of Intestinal Mucosal Integrity in DSS Experimental Colitis
por: Coutinho de Sousa, Beatriz, et al.
Publicado: (2017) -
Computational drug repositioning of atorvastatin for ulcerative colitis
por: Bai, Lawrence, et al.
Publicado: (2021)